
Neurointerventional Medical Device Developer
Financial Services Institutions
According to Gulonhui APP, the latest disclosure of interests filing from the Hong Kong Stock Exchange shows that on September 6, 2021, The Goldman Sachs Group, Inc. increased its long position in HeartCare-B (06609.HK) by 49,650 shares on-market at an average price of HK$142.6297 per share, involving approximately HK$7.082 million.
Following the increase in holdings, The Goldman Sachs Group, Inc.'s latest long position stands at 1,611,112 shares, with the long position percentage rising from 4.95% to 5.10%.